Publications by authors named "Kebing Lv"

Claim this Profile
C
Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies.
Yang Su, Xiaodi Xu, Guang Yang, Bi Chen, Xi Chen, Kebing Lv

Cancer Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Risk Model Based on sCD25 for Early Mortality in Adult Patients with Hemophagocytic Lymphohistiocytosis.
Chunfan Li, Kebing Lv, Yulan Zhou, Xiaoye Cheng, Fei Li

Int J Gen Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ibrutinib as Monotherapy or Combination Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL): A Systematic Review and Meta-analysis.
Yin Li, Chunfan Li, Kebing Lv, Shixuan Wang, Fei Li

Am J Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review.
Shi-Xuan Wang, Fang Wang, Ye-Chao Tu, Yu-Lan Zhou, Song-Tao Tu, Ke-Bing Lv

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine.
Kebing Lv, Fancong Kong, Min Yu, Yulan Zhou, Fei Li

Ann Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Hemophagocytic Lymphohistiocytosis Who Need Intensive Care Can Be Successfully Rescued by Timely Using Etoposide-Based HLH Regimens.
Kebing Lv, Xiaoye Cheng, Yulan Zhou, Min Yu, Shixuan Wang

Int J Gen Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy.
Sheng Zhang, Kebing Lv, Zhen Liu, Ran Zhao, Fei Li

Cell Death Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis.
Shixuan Wang, Kebing Lv, Yulan Zhou, Xiaoye Cheng, Zhiwei Chen

Ann Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Advances in EBV Related Lymphoproliferative Diseases.
Kebing Lv, Ting Yin, Min Yu, Zhiwei Chen, Yulan Zhou

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in CD30- and PD-1-targeted therapies for relapsed or refractory Hodgkin lymphoma.
Huimin Ma, Xin Li, Meng Lin, Kebing Lv, Mingzhi Zhang

Am J Transl Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of new immunotherapy targets for NK/T cell lymphoma.
Kebing Lv, Xin Li, Hui Yu, Xinfeng Chen, Mingzhi Zhang

Am J Transl Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis